Skip to main content

Advertisement

Table 1 Summary of clinical and pathological parameters of analyzed patients, who underwent radical prostatectomy (RP) or transurethral resection (TUR) of the prostate

From: Impairment of IGF2 gene expression in prostate cancer is triggered by epigenetic dysregulation of IGF2-DMR0 and its interaction with KLF4

Clinical and Pathological Parameters Specifications RP-PCa n = 86 RP-BPH n = 47 TUR-BPH n = 13
Age at diagnosis Median (min-max) 67 (54–76) 69 (52–75) 73 (57–88)
Lymph node metastasis N0 (absent), n 63 24 n/a
N1 (present), n 7 3 n/a
NX (unknown), n 16 20 n/a
Prostate specific antigen (preoperative level in ng/ml) “<10”, n 17 9 n/a
“10–15”, n 44 14 n/a
“>15”, n 25 13 n/a
Not known, n 11 n/a
Pathological status T2a-T2c, n 43 15 n/a
T3a-T3b, n 36 11 n/a
T4, n 7 3 n/a
Gleason score “≤7”, n 63 32 n/a
“>7”, n 24 15 n/a
  1. Abbreviations: RP-PCa prostate carcinoma obtained by radical prostatectomy, RP-BPH benign prostate hyperplasia adjacent to PCa obtained by radical prostatectomy, TUR-BPH benign prostate hyperplasia obtained by transurethral resection, n/a not applicable